Videos

Snigdha Vallabhaneni, MD, MPH, discusses the incidence of Candida auris in the United States.

Conan MacDougall, PharmD, discusses some interventions that have been shown to produce negative behavioral changes for antibiotic stewardship.

Belinda Ostrowsky, MD, MPH, explains how to treat patients who expect to receive an antibiotic, but should not.

Kirk Hevener, PharmD, PhD, explains why narrow-spectrum antibiotics are more beneficial for treating C. difficile.

Milena McLaughlin, PharmD, MSc, explains strategies institutions can take to address antimicrobial shortages.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing for off-label indications.

Genovefa Papanicolaou, MD, discusses a new antiviral in development to prevent cytomegalovirus.

Arjun Srinivasan, MD, discusses the "steps" associated with investigating an outbreak.

Otto Schwake, PhD, postulates how Legionella might get into automobile windshield washer fluid and if there is any way to prevent it.

Gonzalo Bearman, MD, MPH, explains what is known about Clostridium difficile prevention and control.

Milena McLaughlin, PharmD, MSc, explains the different ways that antimicrobial shortages can impact patient care.

Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, explains which studies are ideal to run through a meta-analysis.

Lauri A. Hicks, DO, discusses the use of immunotherapy in tackling antibiotic resistance.

Nicola Thompson, PhD, shares what is needed to estimate the burden of healthcare-associated infections in nursing homes.

Snigdha Vallabhaneni, MD, MPH, discusses the keys to controlling the spread of Candida auris.

Lillian Abbo, MD, shares key elements that clinicians should incorporate into antimicrobial stewardship practices.

Jeremy Burrows, DPhil, MA, explains how new antimalarials could change the game for countries where malaria is endemic.

Gonzalo Bearman, MD, MPH, shares a few things to keep in mind when using bundled approaches against C. difficile.

Arjun Srinivasan, MD, explains where outbreaks are most likely to occur within healthcare facilities.

Caetano P. Sabino, BSc, PhD Student, explains how photodynamic therapy works.

Elizabeth Phillips, MD, FRCPC, FRACP, explains the current preferred methods for drug skin testing and desensitization.

Kenneth Mayer, MD, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.

James S. Lewis, PharmD, FIDSA, explains why antimicrobial susceptibility testing is so important when it comes to stewardship programs.

Jason Pogue, PharmD, BCPS-ID, Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, explains why Pseudomonas aeruginosa is one of the World Health Organization’s critical priority pathogens for new research and development priorities.

Davey Legendre, PharmD, MBA, BCPS, sheds light on the prevalence of confirmed beta-lactam allergies in patients.

Benjamin Young, MD, PhD, shares how many catalysts for the HIV epidemic exist within cities.

Arjun Srinivasan, MD, explains the risk of surgeries resulting in outbreaks.

Genovefa Papanicolaou, MD, explains in which patient population is CMV most harmful.

Arjun Srinivasan, MD, explains how healthcare officials can keep the patient at the center of outbreak investigations.

Gonzalo Bearman, MD, MPH, explains when to prescribe antibiotics and suggests to pay attention to the data when it comes to length of treatment.